Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers

Author： Weber J.   Cheinsong-Popov R.   Callow D.   Adams S.   Patou G.   Hodgkin K.   Martin S.   Gotch F.   Kingsman A.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.13, Iss.9, 1995-06, pp. : 831-834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression

By Lindenburg C.E.A.   Stolte I.   Langendam M.W.   Miedema F.   Williams I.G.   Colebunders R.   Weber J.N.   Fisher M.   Coutinho R.A.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2343-2347

Elsevier

Access to resources Recommend Favorite

Immunogenicity of Ty-VLP bearing a CD8 + T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus

By Oliveira-Ferreira J.   Myahira Y.   Layton G.T.   Savage N.   Esteban M.   Rodriguez D.   Rodriguez J.R.   Nussenzweig R.S.   Zavala F.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1863-1869

Elsevier

Access to resources Recommend Favorite

Immunogenicity of Ty-VLP bearing a CD8 + T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus

By Oliveira-Ferreira J.   Myahira Y.   Layton G.T.   Savage N.   Esteban M.   Rodriguez D.   Rodriguez J.R.   Nussenzweig R.S.   Zavala F.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2923-2923

Elsevier

Access to resources Recommend Favorite

P2.4. Psychogériatrie — Gérontopsychiatrie

By  

Les cahiers de l'année gérontologique, Vol. 2, Iss. 3, 2010-09 ,pp. : 332-342

Springer Publishing Company

Access to resources Recommend Favorite

Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP)

By Fernandez F.M.   Conner M.E.   Parwani A.V.   Todhunter D.   Smith K.L.   Crawford S.E.   Estes M.K.   Saif L.J.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1303-1312

Elsevier

Access to resources Recommend Favorite